Beyer W E, Palache A M, Kerstens R, Masurel N
WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, The Netherlands.
Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):65-70. doi: 10.1007/BF01586187.
In order to determine whether there is a difference between genders in reported adverse reactions to inactivated influenza vaccine, a computerized database of serological studies was investigated. A standardized questionnaire was used to evaluate vaccine reactogenicity. A total of 1,800 vaccinees in 14 studies were analyzed separately for two age groups ( < 60 and > or = 60 years of age). Females reported significantly more local reactions than males. The pooled odds ratio for the outcome measure "any local reaction" was 0.32 (95% confidence interval, 0.26-0.40, significant) and 0.54 (95% Cl, 0.41-0.70, significant) for young and elderly adults, respectively. Similar results were obtained for the outcome measure "any systemic reaction." Previous exposure to influenza or influenza vaccine had no influence on reactogenicity. There were no gender differences in sero-responses. In conclusion, gender should be regarded as a predictor of reported reactions to influenza vaccine in both young and elderly adults and should be addressed in future study designs.
为了确定在报告的流感灭活疫苗不良反应方面性别之间是否存在差异,对一个血清学研究的计算机化数据库进行了调查。使用标准化问卷评估疫苗反应原性。对14项研究中的1800名接种者按两个年龄组(<60岁和≥60岁)分别进行分析。女性报告的局部反应显著多于男性。对于“任何局部反应”这一结果指标,年轻成年人的合并比值比为0.32(95%置信区间,0.26 - 0.40,具有显著性),老年人为0.54(95%置信区间,0.41 - 0.70,具有显著性)。对于“任何全身反应”这一结果指标也得到了类似结果。既往接触流感或流感疫苗对反应原性没有影响。血清反应方面不存在性别差异。总之,在年轻和老年成年人中,性别都应被视为报告的流感疫苗反应的一个预测因素,并且在未来的研究设计中应予以考虑。